Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target

Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression

Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,209 · cited 2× · see citing works

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · see citing works

Glial reduction in the subgenual prefrontal cortex in mood disorders

Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · see citing works

Cognitive deficits in depression: Possible implications for functional neuropathology

Austin, M.-P., Mitchell, P., & Goodwin, G. M. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.200 · Cited by 1,154 · see citing works

A meta-analysis of depression severity and cognitive function

McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956 · see citing works

Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response

Pizzagalli, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.166 · Cited by 945 · see citing works

A meta‐analytic study of changes in brain activation in depression

Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008) · Human Brain Mapping · doi:10.1002/hbm.20426 · Cited by 903 · see citing works

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894 · see citing works

Chronic Stress Causes Frontostriatal Reorganization and Affects Decision-Making

Dias-Ferreira, E., Sousa, J. C., Melo, I., Morgado, P., Mesquita, A. R., Cerqueira, J. J., Costa, R. M., & Sousa, N. (2009) · Science · doi:10.1126/science.1171203 · Cited by 858 · see citing works

A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults

Castaneda, A. E., Tuulio‐Henriksson, A., MARTTUNEN, M. J., Suvisaari, J., & Lönnqvist, J. K. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.06.006 · Cited by 755 · see citing works

A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder

Lee, R. S. C., Hermens, D. F., Porter, M. A., & Redoblado-Hodge, M. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.023 · Cited by 737 · see citing works

Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents

Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714 · see citing works

Limbic-frontal circuitry in major depression: a path modeling metanalysis

Seminowicz, D. A., Mayberg, H. S., McIntosh, A. R., Goldapple, K., Kennedy, S., Segal, Z., & Rafi-Tari, S. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.015 · Cited by 710 · see citing works

Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors

Banasr, M., & Duman, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.008 · Cited by 606 · see citing works

The prefrontal cortex as a key target of the maladaptive response to stress

Cerqueira, J. J., Mailliet, F., Almeida, O. F. X., Jay, T. M., & Sousa, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4372-06.2007 · Cited by 599 · see citing works

The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling

Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · cited 4× · see citing works

Cognitive Mechanisms of Treatment in Depression

Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535 · see citing works

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K. D., Gray, N. A., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 499 · see citing works

Chronic Stress Induces Impairment of Spatial Working Memory Because of Prefrontal Dopaminergic Dysfunction

Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H., Chui, D.-H., & Tabira, T. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01568.2000 · Cited by 481 · see citing works

A trans-dimensional approach to the behavioral aspects of depression

Bessa, J. M. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.001.2009 · Cited by 469 · see citing works

Stress-induced prefrontal reorganization and executive dysfunction in rodents

Holmes, A., & Wellman, C. L. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.11.005 · Cited by 469 · see citing works

Neurocognitive Mechanisms in Depression: Implications for Treatment

Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125618 · Cited by 446 · see citing works

GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression

Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430 · see citing works

A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression

Diener, C., Kuehner, C., Brusniak, W., Ubl, B., Wessa, M., & Flor, H. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.04.005 · Cited by 420 · see citing works

Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review

Hasselbalch, B. J., Knorr, U., & Kessing, L. V. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.011 · Cited by 406 · see citing works

Chronic Unpredictable Stress Induces a Cognitive Deficit and Anxiety-Like Behavior in Rats that is Prevented by Chronic Antidepressant Drug Treatment

Bondi, C. O., Rodriguez, G., Gould, G. G., Frazer, A., & Morilak, D. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301410 · Cited by 398 · see citing works

The role of cognitive impairment in general functioning in major depression

Baune, B. T., Miller, R., McAfoose, J., Johnson, M., Quirk, F., & Mitchell, D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2008.12.001 · Cited by 378 · see citing works

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

Kingston, A., Ornstein, P. L., Wright, R. A., Johnson, B. G., Mayne, N. G., Burnett, J. P., Belagaje, R. M., Wu, S., & Schoepp, D. D. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(97)00191-3 · Cited by 369 · see citing works

Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress

Hill, M. N., Patel, S., Carrier, E. J., Rademacher, D. J., Ormerod, B. K., Hillard, C. J., & Gorzalka, B. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300601 · Cited by 363 · see citing works

Pathophysiology of depression: the concept of synaptic plasticity

Duman, R. S. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00654-5 · Cited by 361 · see citing works

Executive functions and updating of the contents of working memory in unipolar depression

Harvey, P. O., Le Bastard, G., Pochon, J. B., Levy, R., Allilaire, J. F., Dubois, B., & Fossati, P. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.003 · Cited by 359 · see citing works

Association between depression severity and neurocognitive function in major depressive disorder: A review and synthesis.

McClintock, S. M., Husain, M. M., Greer, T. L., & Cullum, C. M. (2010) · Neuropsychology · doi:10.1037/a0017336 · Cited by 344 · see citing works

Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Manji, H. K., Duman, R. S., Duman, F. A. R. S., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4260 · Cited by 330 · see citing works

Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress

Li, S., Wang, C., Wang, M., Murakami, Y., & Matsumoto, K. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.01.004 · Cited by 329 · see citing works

The combined cognitive bias hypothesis in depression

Everaert, J., Koster, E. H. W., & Derakshan, N. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.04.003 · Cited by 320 · see citing works

Pattern of impaired working memory during major depression

Rose, E. J., & Ebmeier, K. P. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.003 · Cited by 315 · see citing works

Evidence for continuing neuropsychological impairments in depression

Weiland-Fiedler, P., Erickson, K., Waldeck, T., Luckenbaugh, D. A., Pike, D., Bonne, O., Charney, D. S., & Neumeister, A. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2003.10.009 · Cited by 314 · see citing works

Morphological Correlates of Corticosteroid-Induced Changes in Prefrontal Cortex-Dependent Behaviors

Cerqueira, J., Pêgo, J. M., Taipa, R. J. F., Bessa, J. M., Almeida, O. F. X., & Sousa, N. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1598-05.2005 · Cited by 285 · see citing works

Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder

Schloesser, R. J., Huang, J. Y., Klein, P. S., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301575 · Cited by 256 · see citing works

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

Chaki, S., Yoshikawa, R., Hirota, S., Shimazaki, T., Maeda, M., Kawashima, N., Yoshimizu, T., Yasuhara, A., Sakagami, K., Okuyama, S., et al. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.009 · Cited by 254 · see citing works

Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients

Gorwood, P. A. P. M., Corruble, E., Falissard, B., & Goodwin, G. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07040574 · Cited by 254 · see citing works

Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder.

Matsuo, K., Glahn, D. C., Peluso, M. A. M., Hatch, J. P., Monkul, E. S., Najt, P., Sanches, M., Zamarripa, F., Li, J., Lancaster, J. L., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001894 · Cited by 251 · see citing works

Cognitive Impairment in the Euthymic Phase of Chronic Unipolar Depression

Paradiso, S., Lamberty, G. J., Garvey, M. J., & Robinson, R. G. (1997) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199712000-00005 · Cited by 242 · see citing works

Neurocognition in Depression: Patients on and Off Medication Versus Healthy Comparison Subjects

Gualtieri, C. T., Johnson, L. G., & Benedict, K. B. (2006) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18.2.217 · Cited by 231 · see citing works

Impaired Neuropsychological Performance in Euthymic Patients With Recurring Mood Disorders

Tham, A., Engelbrektson, K., Mathe, A. A., Johnson, L., Olsson, E., & Aberg-Wistedt, A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0105 · Cited by 229 · see citing works

Executive dysfunction predicts nonresponse to fluoxetine in major depression

Dunkin, J. J., Leuchter, A. F., Cook, I. A., Kasl-Godley, J. E., Abrams, M., & Rosenberg-Thompson, S. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00157-3 · Cited by 221 · see citing works

Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis

Reppermund, S., Ising, M., Lucae, S., & Zihl, J. (2009) · Psychological Medicine · doi:10.1017/s003329170800411x · Cited by 219 · see citing works

A History of Corticosterone Exposure Regulates Fear Extinction and Cortical NR2B, GluR2/3, and BDNF

Gourley, S. L., Kedves, A. T., Olausson, P., & Taylor, J. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.123 · Cited by 218 · see citing works

Structural and cognitive deficits in remitting and non-remitting recurrent depression: A voxel-based morphometric study

Li, C., Lin, C., Chou, K., Chen, I.-Y., Hsieh, J., Wu, C., Lin, W.-C., & Su, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.021 · Cited by 214 · see citing works

Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression

Karolewicz, B., Maciag, D., O'Dwyer, G., Stockmeier, C. A., Feyissa, A. M., & Rajkowska, G. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990587 · Cited by 203 · see citing works

Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, its polysialylation, and L1

Sandi, C., Merino, J. J., Cordero, M. I., Touyarot, K., & Venero, C. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00484-x · Cited by 201 · see citing works

Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression

Abe, O., Yamasue, H., Kasai, K., Yamada, H., Aoki, S., Inoue, H., Takei, K., Suga, M., Matsuo, K., Kato, T., et al. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.07.007 · Cited by 201 · see citing works

Cell atrophy and loss in depression: reversal by antidepressant treatment

Banasr, M., Dwyer, J. M., & Duman, R. S. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.002 · Cited by 201 · see citing works

Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment

Elizalde, N., Gil-Bea, F. J., Ramírez, M. J., Aisa, B., Lasheras, B., del Rı́o, J. A., & Tordera, R. M. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1035-1 · Cited by 195 · see citing works

Deficits in hippocampal and anterior cingulate functioning during verbal declarative memory encoding in midlife major depression

Bremner, J. D., Vythilingam, M., Vermetten, E., Vaccarino, V., & Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.4.637 · Cited by 192 · see citing works

Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder

Salvadore, G., Nugent, A. C., Lemaître, H., Luckenbaugh, D. A., Tinsley, R., Cannon, D. M., Neumeister, A., Zarate, C. A., & Drevets, W. C. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.011 · Cited by 188 · see citing works

A meta‐analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment

Wagner, S., Doering, B., Helmreich, I., Lieb, K., & Tadić, A. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01762.x · Cited by 180 · see citing works

Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests

Rohling, M. L., Green, P., Allen, L. M., & Iverson, G. L. (2002) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(01)00109-3 · Cited by 180 · see citing works

Attenuated Left Prefrontal Activation during a Verbal Fluency Task in Patients with Depression

Okada, G., Okamoto, Y., Morinobu, S., Yamawaki, S., & Yokota, N. (2003) · Neuropsychobiology · doi:10.1159/000068871 · Cited by 178 · see citing works

The neuropsychological profile in unipolar depression

Elliott, R. (1998) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01235-2 · Cited by 176 · see citing works

Specific Configuration of Dendritic Degeneration in Pyramidal Neurons of the Medial Prefrontal Cortex Induced by Differing Corticosteroid Regimens

Cerqueira, J., Taipa, R. J. F., Uylings, H. B. M., Almeida, O. F. X., & Sousa, N. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl108 · Cited by 171 · see citing works

Neuropsychological Performance in Patients With Depression is Associated With Clinical, Etiological and Genetic Risk Factors

Naismith, S. L., Hickie, I. B., Turner, K., Little, C. L., Winter, V., Ward, P. B., Wilhelm, K. A., Mitchell, P. B., & Parker, G. B. (2003) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.25.6.866.16472 · Cited by 170 · see citing works

Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression

Clark, L., Kempton, M. J., Scarnà, A., Grasby, P. M., & Goodwin, G. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.007 · Cited by 170 · see citing works

Reduced Density of Calbindin Immunoreactive GABAergic Neurons in the Occipital Cortex in Major Depression: Relevance to Neuroimaging Studies

Maciąg, D., Hughes, J., O'Dwyer, G., Pride, Y., Stockmeier, C. A., Sanacora, G., & Rajkowska, G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.10.027 · Cited by 170 · see citing works

Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder

Smith, D. J., Muir, W. J., & Blackwood, D. H. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00275.x · Cited by 170 · see citing works

Mood disorders: Regulation by metabotropic glutamate receptors

Pilc, A., Chaki, S., Nowak, G., & Witkin, J. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.021 · Cited by 163 · see citing works

Chronic mild stress impairs cognition in mice: From brain homeostasis to behavior

Li, S., Wang, C., Wang, W., Dong, H., Hou, P., & Tang, Y. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.02.010 · Cited by 163 · see citing works

Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

Herrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Guzmán, D., Guàrdia-Olmos, J., Hinojosa-Calvo, E., & Herrera-Abarca, J. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.015 · Cited by 160 · see citing works

A Longitudinal Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Depression After Antidepressant Therapy

Walsh, N., Williams, S., Brammer, M. J., Bullmore, E. T., Kim, J., John Suckling, A., Mitterschiffthaler, M. T., Cleare, A. J., Pich, E. M., Mehta, M. A., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.022 · Cited by 160 · see citing works

Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent

Higgins, G. A., Ballard, T. M., Kew, J. N. C., Richards, J. G., Kemp, J. A., Adam, G., Woltering, T. J., Nakanishi, S., & Mutel, V. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.018 · Cited by 158 · see citing works

An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study

Spronk, D. B., Arns, M., Barnett, K. J., Cooper, N. J., & Gordon, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.021 · Cited by 147 · see citing works

Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study

Naismith, S. L., Longley, W. A., Scott, E. M., & Hickie, I. B. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-32 · Cited by 146 · see citing works

Performance on a Virtual Reality Spatial Memory Navigation Task in Depressed Patients

Gould, N. F., Holmes, M. K., Fantie, B. D., Luckenbaugh, D. A., Pine, D. S., Gould, T. D., Burgess, N., Manji, H. K., & Zarate, C. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.516 · Cited by 140 · see citing works

Executive function improvement upon remission of recurrent unipolar depression

Biringer, E., Lundervold, A., Stordal, K., Mykletun, A., Egeland, J., Bottlender, R., & Lund, A. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0577-7 · Cited by 138 · see citing works

Cognitive and neural correlates of depression-like behaviour in socially defeated mice: an animal model of depression with cognitive dysfunction

Yu, T., Guo, M., Garza, J., Rendon, S., Sun, X.-L., Zhang, W., & Lu, X.-Y. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000945 · Cited by 137 · see citing works

Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests

Rohling, M. L., Green, P. E., Allen, L. M., et al. (2002) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/17.3.205 · Cited by 137 · see citing works

Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities

Neu, P., Bajbouj, M., Schilling, A. M., Godemann, F., Berman, R. M., & Schlattmann, P. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.06.004 · Cited by 131 · see citing works

Hippocampal low-frequency stimulation and chronic mild stress similarly disrupt fear extinction memory in rats.

Garcia, R., Spennato, G., Nilsson-Todd, L., Moreau, J., & Deschaux, O. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.10.005 · Cited by 126 · see citing works

Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression

Feyissa, A. M., Woolverton, W. L., Miguel-Hidalgo, J. J., Wang, Z., Kyle, P. B., Hasler, G., Stockmeier, C. A., Iyo, A. H., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.018 · Cited by 126 · see citing works

1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism

Chowdhury, G. M. I., Behar, K. L., Cho, W., Thomas, M. A., Rothman, D. L., & Sanacora, G. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.006 · Cited by 125 · see citing works

Cognitive deficits in the rat chronic mild stress model for depression: Relation to anhedonic-like responses

Henningsen, K., Andreasen, J. T., Bouzinova, E. V., Jayatissa, M. N., Jensen, M. S., Redrobe, J. P., & Wiborg, O. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.039 · Cited by 125 · see citing works

Identifying a cognitive impairment subgroup in adults with mood disorders

Iverson, G. L., Brooks, B. L., Langenecker, S. A., & Young, A. H. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.001 · Cited by 124 · see citing works

Disrupted resting-state functional connectivity of the hippocampus in medication-naïve patients with major depressive disorder

Cao, X., Liu, Z., Xu, C., Li, J., Gao, Q., Sun, N., Xu, Y., Ren, Y., Yang, C., & Zhang, K. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.002 · Cited by 118 · see citing works

Hot and cold cognition in unmedicated depressed subjects with bipolar disorder

Roiser, J. P., Cannon, D. M., Gandhi, S. K., Tavares, J. T., Erickson, K., Wood, S. E., Klaver, J. M., Clark, L., Zarate, C. A., Sahakian, B. J., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00669.x · Cited by 117 · see citing works

mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants

Chaki, S., Ago, Y., Pałucha-Poniewiera, A., Matrisciano, F., & Pilc, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.022 · Cited by 114 · see citing works

Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists

Koike, H., Iijima, M., & Chaki, S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.034 · Cited by 114 · see citing works

Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study

Milne, A. M. B., MacQueen, G. M., & Hall, G. B. C. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110004 · Cited by 107 · see citing works

Abnormal Hippocampal Functioning and Impaired Spatial Navigation in Depressed Individuals: Evidence From Whole-Head Magnetoencephalography

Cornwell, B. R., Salvadore, G., Colon-Rosario, V., Latov, D. R., Holroyd, T., Carver, F. W., Coppola, R., Manji, H. K., Zarate, C. A., & Grillon, C. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09050614 · Cited by 98 · see citing works

Chronic treatment with desipramine improves cognitive performance of rats in an attentional set-shifting test

Lapiz, M. D. S., Bondi, C. O., & Morilak, D. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301235 · Cited by 95 · see citing works

Long-lasting cognitive impairment in unipolar major depression: a 6-month follow-up study

Hammar, Å., Lund, A., & Hugdahl, K. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00075-1 · Cited by 88 · see citing works

Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by α1-adrenergic receptors in medial prefrontal cortex

Bondi, C. O., Jett, J. D., & Morilak, D. A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.016 · Cited by 88 · see citing works

Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects

Gorlyn, M., Keilp, J. G., Grunebaum, M. F., Taylor, B. P., Oquendo, M. A., Bruder, G. E., Stewart, J. W., Zalsman, G., & Mann, J. J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0084-x · Cited by 84 · see citing works

Working‐memory fMRI reveals cingulate hyperactivation in euthymic major depression

Schöning, S., Zwitserlood, P., Engelien, A., Behnken, A., Kugel, H., Schiffbauer, H., Lipina, K., Pachur, C., Kersting, A., Dannlowski, U., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20702 · Cited by 81 · see citing works

Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression

Campo, B., Kalinichev, M., Lambeng, N., Yacoubi, M. E., Royer-Urios, I., Schneider, M. P., Legrand, C., Parron, D., Girard, F., Bessif, A., et al. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.627485 · Cited by 80 · see citing works

Persistent non-verbal memory impairment in remitted major depression — Caused by encoding deficits?

Behnken, A., Schöning, S., Gerß, J., Konrad, C., de Jong-Meyer, R., Zwanzger, P., & Arolt, V. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.010 · Cited by 79 · see citing works

Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder

Herrera-Guzmán, I., Gudayol-Ferré, E., Lira-Mandujano, J., Herrera-Abarca, J., Herrera-Guzmán, D., Montoya-Pérez, K., & Guardia-Olmos, J. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.04.012 · Cited by 78 · see citing works

Cognitive dysfunctions in recovered melancholic patients

Marcos, T., Salamero, M., Gutiérrez, F., Catalán, R., Gastó, C., & Lázaro, L. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90071-x · Cited by 75 · see citing works

Low episodic memory performance as a premorbid marker of depression: evidence from a 3‐year follow‐up

Airaksinen, E., Wahlin, Å., Forsell, Y., & Larsson, M. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00932.x · Cited by 74 · see citing works

Changes in directed attention and short-term memory in depression

Williams, R. A., Hagerty, B. M., Cimprich, B., Therrien, B. A., Bay, E., & Oe, H. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00012-1 · Cited by 73 · see citing works

Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression

Bespalov, A., van Gaalen, M. M., Sukhotina, I. A., Wicke, K. M., Mezler, M., Schoemaker, H., & Groß, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.089 · Cited by 68 · see citing works

Neuropsychological changes and treatment response in severe depression

Douglas, K. M., Porter, R., Knight, R. G., & Maruff, P. T. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.080713 · Cited by 67 · see citing works

Brain imaging correlates of cognitive impairment in depression

Thomas, E. J. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.030.2009 · Cited by 64 · see citing works

Stress induced cognitive deficit is differentially modulated in BALB/c and C57Bl/6 mice

Palumbo, M. L., Canzobre, M. C., Pascuan, C. G., Rı́os, H., Wald, M. R., & Genaro, A. M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.005 · Cited by 61 · see citing works

Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats

Orsetti, M., Colella, L., Dellarole, A., Canonico, P. L., & Ghi, P. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006705 · Cited by 60 · see citing works

Do memory complaints represent impaired memory performance in patients with major depressive disorder?

Mowla, A., Ashkani, H., Ghanizadeh, A. J., Dehbozorgi, G., Sabayan, B., & Chohedri, A. H. (2007) · Depression and Anxiety · doi:10.1002/da.20343 · Cited by 59 · see citing works

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039

Pałucha-Poniewiera, A., Wierońska, J. M., Brański, P., Stachowicz, K., Chaki, S., & Pilc, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1978-5 · Cited by 57 · see citing works

Memory related dysregulation of hippocampal function in major depressive disorder

Fairhall, S. L., Sharma, S., Magnusson, J. E., & Murphy, B. A. (2010) · Biological Psychology · doi:10.1016/j.biopsycho.2010.09.002 · Cited by 57 · see citing works

Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys

Spinelli, S., Ballard, T. M., Gatti‐McArthur, S., Richards, G. J., Kapps, M., Woltering, T. J., Wichmann, J., Stadler, H., Feldon, J., & Pryce, C. R. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2126-x · Cited by 57 · see citing works

Causal evidence for the involvement of the neural cell adhesion molecule, NCAM, in chronic stress‐induced cognitive impairments

Bisaz, R., Schachner, M., & Sandi, C. (2009) · Hippocampus · doi:10.1002/hipo.20723 · Cited by 56 · see citing works

New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways

Vidal, R., Pilar-Cuéllar, F., Dos-Anjos, S., Linge, R., Treceño, B., Vargas, V. I., Rodríguez‐Gaztelumendi, A., Mostany, R., Castro, E., Díaz, Á., et al. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795164086 · Cited by 55 · see citing works

Activation of metabotropic glutamate receptor type 2/3 supports the involvement of the hippocampal mossy fiber pathway on contextual fear memory consolidationPreprint

Daumas, S., Ceccom, J., Halley, H., Francès, B., & Lassalle, J. (2009) · Learning & Memory · doi:10.1101/lm.1418309 · Cited by 47 · see citing works

Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: Comparison with sertraline

Andreasen, J. T., Henningsen, K., Bate, S., Christiansen, S., & Wiborg, O. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391831 · Cited by 46 · see citing works

Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats

Shimazaki, T., Kaku, A., & Chaki, S. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.006 · Cited by 43 · see citing works

Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice

Kawasaki, T., Ago, Y., Yano, K., Araki, R., Washida, Y., Onoe, H., Chaki, S., Nakazato, A., Hashimoto, H., Baba, A., et al. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.009 · Cited by 42 · see citing works

AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder

Gibbons, A. S., Brooks, L., Scarr, E., & Dean, B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.001 · Cited by 41 · see citing works

The Metabotropic Glutamate (mGLU)2/3 Receptor Antagonist LY341495 [2 S-2-Amino-2-(1 S,2 S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic Acid] Stimulates Waking and Fast Electroencephalogram Power and Blocks the Effects of the mGLU2/3 Receptor Agonist LY379268 [(-)-2-Oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in Rats

Feinberg, I., Schoepp, D. D., Hsieh, K.-C., Darchia, N., & Campbell, I. G. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076547 · Cited by 40 · see citing works

Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists

Woltering, T. J., Wichmann, J., Goetschi, E., Knoflach, F., Ballard, T. M., Huwyler, J., & Gatti, S. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.125 · Cited by 39 · see citing works

The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder

Gudayol‐Ferré, E., Herrera‐Guzmán, I., Camarena, B., Cortés‐Penagos, C., Herrera‐Abarca, J. E., Martínez‐Medina, P., la Cruz, D. C.-D., Hernández, S., Genis, A. D., Carrillo-Guerrero, M. Y., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.002 · Cited by 39 · see citing works

A GENOTYPE-ENDOPHENOTYPE-PHENOTYPE PATH MODEL OF DEPRESSED MOOD: INTEGRATING COGNITIVE AND EMOTIONAL MARKERS

Gatt, J. M., Clark, C. R., Kemp, A. H., Liddell, B. J., Dobson‐Stone, C., Kuan, S. A., Schofield, P. R., & Williams, L. M. (2007) · Journal of Integrative Neuroscience · doi:10.1142/s0219635207001398 · Cited by 37 · see citing works

Cognitive Performance in Patients Recovering from Depression

Kuny, S., & Stassen, H. H. (2010) · Psychopathology · doi:10.1159/000284922 · Cited by 37 · see citing works

Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age

Frank, E., Newell, K. A., & Huang, X. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.008 · Cited by 31 · see citing works

Neuropsychology of affective disorders

Roiser, J. P., Rubinsztein, J. S., & Sahakian, B. J. (2009) · Psychiatry · doi:10.1016/j.mppsy.2008.11.007 · Cited by 24 · see citing works

Contextual recognition memory deficits in major depression are suppressed by cognitive support at encoding

Corrêa, M. S., Balardin, J. B., Caldieraro, M. A., Fleck, M. P. D. A., Argimon, I. I. D. L., Luz, C., & Bromberg, E. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.11.001 · Cited by 18 · see citing works

Using a cognitive endophenotype to identify risk genes for depression

Haeffel, G. J., Eastman, M., & Grigorenko, E. L. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.060 · Cited by 17 · see citing works

Neural basis of recollection in first‐episode major depression

van Eijndhoven, P., van Wingen, G. A., Fernández, G., Rijpkema, M., Pop‐Purceleanu, M., Verkes, R. J., Buitelaar, J. K., & Tendolkar, I. (2012) · Human Brain Mapping · doi:10.1002/hbm.21439 · Cited by 15 · see citing works

Antagonism of metabotropic glutamate group II receptors in the potential treatment of neurological and neuropsychiatric disorders

Witkin, J. M., & Eiler, W. J. A. (2006) · Drug Development Research · doi:10.1002/ddr.20144 · Cited by 12 · see citing works

The investigation and correction of recall bias for an ordinal response in a case‐control study

Barry, D., & Livingstone, V. (2005) · Statistics in Medicine · doi:10.1002/sim.2238 · Cited by 10 · see citing works

The density, size and spatial pattern distribution of neurons and glia in area 9 prefrontal cortex in schizophrenia, bipolar disorder and major depression

Cotter, D., Mackay, D., Beasley, C. L., Everall, I., & Landau, S. (2002) · Research Portal (King's College London) · Cited by 8 · see citing works

P60 ANTIDEPRESSANT AND ANTI-OCD-LIKE ACTIVITY OF MGS0039, A POTENT AND SELECTIVE GROUP II METABOTROPIC GLUTAMATE RECEPTOR ANTAGONIST

Shimazaki, T., Hirota-Okuno, S., Iijima, M., Yoshimizu, T., & Chaki, S. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00100 · Cited by 5 · see citing works

Functional impairment recovers after episodes of major depression

Biringer, E. (2005) · Evidence-Based Mental Health · doi:10.1136/ebmh.8.3.65 · Cited by 3 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Development of allosteric modulators of GPCRs for treatment of CNS disorders

Nickols, H. H., & Conn, P. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.013 · Cited by 227 · see citing works

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders

Hashimoto, K., Malchow, B., Falkai, P., & Schmitt, A. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0399-y · Cited by 219 · see citing works

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

Lindsley, C. W., Emmitte, K. A., Hopkins, C. R., Bridges, T. M., Gregory, K. J., Niswender, C. M., & Conn, P. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00656 · Cited by 183 · see citing works

Depressive symptoms in neurodegenerative diseases

Baquero, M. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i8.682 · Cited by 178 · see citing works

The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy

Bukke, V. N., Moola, A., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 160 · see citing works

Neuroplastic Correlates in the mPFC Underlying the Impairment of Stress-Coping Ability and Cognitive Flexibility in Adult Rats Exposed to Chronic Mild Stress during Adolescence

Zhang, Y., Shao, F., Wang, Q., Xie, X., & Wang, W. (2017) · Neural Plasticity · doi:10.1155/2017/9382797 · Cited by 125 · see citing works

Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression

Lindemann, L., Porter, R. H., Scharf, S. H., Kuennecke, B., Bruns, A., von Kienlin, M., Harrison, A. C., Paehler, A., Funk, C., Gloge, A., et al. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222463 · Cited by 107 · see citing works

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Jaso, B. A., Niciu, M. J., Iadarola, N. D., Lally, N., Richards, E. M., Park, M., Ballard, E. D., Nugent, A. C., Machado‐Vieira, R., & Zarate, C. A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160321123221 · Cited by 98 · see citing works

Metabotropic glutamate receptors as drug targets: what's new?

Nicoletti, F., Bruno, V., Ngomba, R. T., Gradini, R., & Battaglia, G. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.002 · Cited by 90 · see citing works

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications

Willard, S. S., & Koochekpour, S. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6475 · Cited by 86 · see citing works

Metabotropic glutamatergic receptors and their ligands in drug addiction

Pomierny-Chamioło, L., Rup, K., Pomierny, B., Niedzielska, E., Kalivas, P. W., & Filip, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.012 · Cited by 80 · see citing works

mGlu2/3 Receptor Antagonists as Novel Antidepressants

Chaki, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.03.008 · Cited by 73 · see citing works

Neurotransmitter Targeting in the Treatment of Depression

Blier, P. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12084su1c.04 · Cited by 76 · see citing works

Alteration by p11 of mGluR5 localization regulates depression-like behaviors

Lee, K.-W., Westin, L., Kim, J., Chang, J. C., Oh, Y.-S., Amreen, B., Gresack, J. E., Flajolet, M., Kim, D. J., Aperia, A. C., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.132 · Cited by 74 · see citing works

Enriched environment ameliorates depression-induced cognitive deficits and restores abnormal hippocampal synaptic plasticity

Mahati, K., Bhagya, V. R., Christofer, T., Sneha, A., & Rao, B. S. S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.08.017 · Cited by 74 · see citing works

The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders

Bruno, V., Caraci, F., Copani, A., Matrisciano, F., Nicoletti, F., & Battaglia, G. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.044 · Cited by 71 · see citing works

Effects of adolescent social stress and antidepressant treatment on cognitive inflexibility and Bdnf epigenetic modifications in the mPFC of adult mice

Xu, H., Wang, J., Zhang, K., Zhao, M., Ellenbroek, B. A., Shao, F., & Wang, W. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.11.013 · Cited by 71 · see citing works

Cognition as a target in major depression: new developments.

Solé, B., Jiménez, E., Martinez-Aran, A., & Vieta, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.004 · Cited by 68 · see citing works

Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents

Engers, J. L., Rodriguez, A. L., Konkol, L. C., Morrison, R. D., Thompson, A. D., Byers, F. W., Blobaum, A. L., Chang, S., Venable, D. F., Loch, M. T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01005 · Cited by 66 · see citing works

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels

Hamdani, N., Daban, C., Lajnef, M., Gadel, R., Corvoisier, P. L., Delavest, M., Carde, S., Lépine, J., Jamain, S., Houenou, J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.038 · Cited by 65 · see citing works

International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors

Gregory, K. J., & Goudet, C. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.019133 · Cited by 64 · see citing works

Role of Adult Hippocampal Neurogenesis in Cognition in Physiology and Disease: Pharmacological Targets and Biomarkers

Costa, V., Lugert, S., & Jagasia, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_4 · Cited by 61 · see citing works

Mild Cognitive Impairment in Patients with Moderate to Severe Chronic Plaque Psoriasis

Gisondi, P., Sala, F., Alessandrini, F., Avesani, V., Zoccatelli, G., Beltramello, A., Moretto, G., Gambina, G., & Girolomoni, G. (2014) · Dermatology · doi:10.1159/000357220 · Cited by 60 · see citing works

Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study

Chokka, P. R., Bougie, J. K., Proulx, J., Tvistholm, A. H., & Ettrup, A. (2019) · CNS Spectrums · doi:10.1017/s1092852919000786 · Cited by 55 · see citing works

Assessment in work productivity and the relationship with cognitive symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)

Chokka, P., Bougie, J., Rampakakis, E., & Proulx, J. (2019) · CNS Spectrums · doi:10.1017/s1092852918000913 · Cited by 48 · see citing works

Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor

Pérez‐Benito, L., Doornbos, M. L. J., Cordomí, A., Peeters, L., Lavreysen, H., Pardo, L., & Tresadern, G. (2017) · Structure · doi:10.1016/j.str.2017.05.021 · Cited by 45 · see citing works

Effects of Duloxetine Treatment on Cognitive Flexibility and BDNF Expression in the mPFC of Adult Male Mice Exposed to Social Stress during Adolescence

Xu, H., Zhang, Y., Zhang, F., Yuan, S., Shao, F., & Wang, W. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00095 · Cited by 42 · see citing works

Novel Glutamatergic Treatments for Severe Mood Disorders

Park, M., Niciu, M. J., & Zarate, C. A. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0050-5 · Cited by 40 · see citing works

Design and Synthesis of N -Aryl Phenoxyethoxy Pyridinones as Highly Selective and CNS Penetrant mGlu 3 NAMs

Engers, J. L., Bollinger, K. A., Weiner, R. L., Rodriguez, A. L., Long, M. F., Breiner, M. M., Chang, S., Bollinger, S. R., Bubser, M., Jones, C. K., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00249 · Cited by 41 · see citing works

A New Look on Long-COVID Effects: The Functional Brain Fog Syndrome

Orfei, M. D., Porcari, D. E., D’Arcangelo, S., Maggi, F., Russignaga, D., & Ricciardi, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195529 · Cited by 37 · see citing works

Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain

Zuena, A. R., Maftei, D., Alemà, G., Moro, F. D., Lattanzi, R., Casolini, P., & Nicoletti, F. (2018) · Molecular Pain · doi:10.1177/1744806918808987 · Cited by 37 · see citing works

Clinical investigations of compounds targeting metabotropic glutamate receptors

Witkin, J. M., Pandey, K. P., & Smith, J. L. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173446 · Cited by 37 · see citing works

Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2

Felts, A. S., Rodriguez, A. L., Smith, K. A., Engers, J. L., Morrison, R. D., Byers, F. W., Blobaum, A. L., Locuson, C. W., Chang, S., Venable, D. F., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01371 · Cited by 35 · see citing works

Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets

Prakash, A. K., Kalra, J., Mani, V., Ramasamy, K., & Majeed, A. B. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.988709 · Cited by 35 · see citing works

Chlorbipram: A novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer

Zhang, M.-Z., Zhou, Z., Yuan, X., Cheng, Y., Bi, B., Gong, M., Chen, Y.-P., & Xu, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.055 · Cited by 33 · see citing works

Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex

Kiritoshi, T., & Neugebauer, V. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.003 · Cited by 33 · see citing works

Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators

O’Brien, D. E., Shaw, D. M., Cho, H. P., Cross, A. J., Wesolowski, S. S., Felts, A. S., Bergare, J., Elmore, C. S., Lindsley, C. W., Niswender, C. M., et al. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.110114 · Cited by 32 · see citing works

S100A10 and its binding partners in depression and antidepressant actions

Chen, M. X., Oh, Y., & Kim, Y. D. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.953066 · Cited by 32 · see citing works

Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction

Martin, B., Wang, R., Cong, W., Daimon, C. M., Wu, W. W., Ni, B., Becker, K. G., Lehrmann, E., Wood, W. H., Zhang, Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.773820 · Cited by 29 · see citing works

Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present)

Célanire, S., Sebhat, I. K., Wichmann, J., Mayer, S., Schann, S., & Gatti, S. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.983899 · Cited by 28 · see citing works

Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage

Motolese, M., Mastroiacovo, F., Cannella, M., Bucci, D., Gaglione, A., Riozzi, B., Lütjens, R., Poli, S. M., Célanire, S., Bruno, V., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0158-2 · Cited by 28 · see citing works

A systematic review on neuropsychological function in bipolar disorders type I and II and subthreshold bipolar disorders—something to think about

King, S., Stone, J. M., Cleare, A. J., & Young, A. H. (2019) · CNS Spectrums · doi:10.1017/s1092852918001463 · Cited by 27 · see citing works

Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases

Khotimchenko, Y. S., Silachev, D. N., & Katanaev, V. L. (2022) · Marine Drugs · doi:10.3390/md20110708 · Cited by 25 · see citing works

Subregion-specific proteomic signature in the hippocampus for recognition processes in adult mice

von Ziegler, L. M., Selevsek, N., Tweedie-Cullen, R. Y., Kremer, E., & Mansuy, I. M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.079 · Cited by 23 · see citing works

mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development

Chaki, S., & Watanabe, M. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01561-6 · Cited by 25 · see citing works

GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Inkster, B., Zai, G. C., Lewis, G., & Miskowiak, K. W. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0270-z · Cited by 23 · see citing works

In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu 2/3 receptor antagonist

Witkin, J. M., Ornstein, P. L., Mitch, C. H., Li, R., Smith, S. C., Heinz, B. A., Wang, X.-S., Xiang, C., Carter, J. H., Anderson, W. H., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.021 · Cited by 22 · see citing works

Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure

Gottschalk, M. G., Mortas, P., Haman, M., Özcan, S., Biemans, B., & Bahn, S. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.002 · Cited by 21 · see citing works

mGlu2/3 receptor antagonists

Chaki, S. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.03.004 · Cited by 21 · see citing works

Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders

Lütjens, R., & Rocher, J. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.01.001 · Cited by 20 · see citing works

Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensor

Doornbos, M. L. J., der Linden, I. V., Vereyken, L., Tresadern, G., IJzerman, A. P., Lavreysen, H., & Heitman, L. H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.026 · Cited by 20 · see citing works

Major Depression in Comorbidity with Substance use Disorders: Patients’ Features and Clinical-Neurobiological Rationale of Antidepressant Treatments

Filippis, S. D., Martinotti, G., Nicoletti, F., Mastrostefano, A., Trovini, G., Pugliese, A., & Nicola, M. D. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240827165327 · Cited by 20 · see citing works

Genetic deletion of mGlu2 metabotropic glutamate receptors improves the short-term outcome of cerebral transient focal ischemia

Mastroiacovo, F., Moyanova, S. G., Cannella, M., Gaglione, A., Verhaeghe, R., Bozza, G., Madonna, M., Motolese, M., Traficante, A., Riozzi, B., et al. (2017) · Molecular Brain · doi:10.1186/s13041-017-0319-6 · Cited by 18 · see citing works

Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression

Wood, C. M., Wafford, K. A., McCarthy, A. P., Hewes, N., Shanks, E., Lodge, D., & Robinson, E. S. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.013 · Cited by 17 · see citing works

Psoriasis and Dementia: A Cross-sectional Study of 121,801 Patients

Kridin, K., Linder, D., Shalom, G., Piaserico, S., Babaev, M., Freud, T., Comaneshter, D. S., & Cohen, A. D. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3595 · Cited by 17 · see citing works

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

Krysta, K., Krzystanek, M., Janas-Kozik, M. H., Klasik, A., & Krupka-Matuszczyk, I. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1282-3 · Cited by 18 · see citing works

Advancements in research on the effects of panax notoginseng saponin constituents in ameliorating learning and memory disorders

Liu, S., Wang, M., Haiyan, X., Ye, J., Cao, L., Li, W., & Sun, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28581 · Cited by 16 · see citing works

Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants

Chaki, S., Koike, H., & Fukumoto, K. (2019) · Chronic Stress · doi:10.1177/2470547019837712 · Cited by 16 · see citing works

Rapid‐acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms

Wang, S., Tang, S., Huang, J., & Chen, H. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100922 · Cited by 14 · see citing works

Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2

Doornbos, M. L. J., Vermond, S. C., Lavreysen, H., Tresadern, G., IJzerman, A. P., & Heitman, L. H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.014 · Cited by 13 · see citing works

Are mGluR2/3 Inhibitors Potential Compounds for Novel Antidepressants?

Yajie, J., Zou, M., Ren, T., & Wang, Y. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01310-8 · Cited by 13 · see citing works

Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 – present)

Qunies, A. M., & Emmitte, K. A. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1903431 · Cited by 10 · see citing works

Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus

Panaccione, I., Iacovelli, L., di Nuzzo, L., Nardecchia, F., Mauro, G., Janiri, D., Blasi, A. D., Sani, G., Nicoletti, F., & Orlando, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.029 · Cited by 10 · see citing works

1,3,5‐Trisubstituted Pyrazoles as Potent Negative Allosteric Modulators of the mGlu 2/3 Receptors

Gool, M. V., de Diego, S. A. A., Delgado, Ó., Trabanco, A. A., Jourdan, F. L., Macdonald, G. J., Somers, M., & Donck, L. V. (2017) · ChemMedChem · doi:10.1002/cmdc.201700101 · Cited by 10 · see citing works

The effects and possible mechanisms of whole-body vibration on cognitive function: A narrative review

Yang, H., Gao, J., Wang, H., Ma, X.-M., Liu, B.-Y., Song, Q. Y., Cheng, H., Li, S., Long, Z.-Y., Lu, X., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149392 · Cited by 9 · see citing works

Food for thought: understanding the value, variety and usage of management algorithms for major depressive disorder

Katzman, M. A., Anand, L., Furtado, M., & Chokka, P. R. (2014) · Psychiatry Research · doi:10.1016/s0165-1781(14)70002-2 · Cited by 9 · see citing works

Cognitive impairment induced by permanent bilateral common carotid occlusion exacerbates depression-related behavioral, biochemical, immunological and neuronal markers

Khojasteh, F., Nahavandi, A., Mehrpouya, S., Homberg, J. R., Mirzamohammadi, S., Raufi, S., Soleimani, M., & Barati, M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.056 · Cited by 9 · see citing works

Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder

Maruff, P. T., & Jaeger, J. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.003 · Cited by 9 · see citing works

mGlu2/3 receptor as a novel target for rapid acting antidepressants

Chaki, S. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.04.001 · Cited by 8 · see citing works

Possible applications of rac-hopantenic acid in the treatment of anxiety and depressive disorders in patients with chronic cerebral ischemia

Guekht, A. B., Сергеевна, К. Л., Аведисова, А. С., Marachev, M. P., Валерьевна, З. К., Дашкина, Г. К., & Kulikova, E. V. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611611145-57 · Cited by 8 · see citing works

Role of vortioxetine in the treatment of neuropathic pain

Montero, A. A., & de Vasconcelos, S. R. P. (2022) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2022.09.003 · Cited by 7 · see citing works

An integrated multi-level analysis reveals learning-memory deficits and synaptic dysfunction in the rat model exposure to austere environment

Li, N., Gao, Y., Zhang, Y., & Deng, Y. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104887 · Cited by 7 · see citing works

Allosteric modulators targeting GPCRs

López-Rodríguez, M. L., Benhamú, B., & Vázquez‐Villa, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00011-8 · Cited by 7 · see citing works

Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice

Busceti, C. L., Menna, L. D., Castaldi, S., D’Errico, G., Taddeucci, A., Bruno, V., Fornai, F., Pittaluga, A., Battaglia, G., & Nicoletti, F. (2024) · eNeuro · doi:10.1523/eneuro.0523-23.2024 · Cited by 5 · see citing works

Papel de vortioxetina en el tratamiento del dolor neuropático

Montero, A. A., & de Vasconcelos, S. R. P. (2021) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2021.04.001 · Cited by 4 · see citing works

Variants of the Spontaneous Recognition Procedure Assessing Multisensory Integration Reveal Behavioral Alterations in Rodent Models of Psychiatric and Neurological Disorders

Marks, W. N., Parker, M., & Howland, J. G. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-812012-5.00007-0 · Cited by 4 · see citing works

Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.3 · Cited by 1 · see citing works

Acute effects of aerobic and resistance exercise on craving and cognitive function in individuals with heroin use disorder

Wang, X., Li, M., Yang, Y., Ouyang, X., Zhu, T., Tao, W., Zhou, C., & Wang, D. (2025) · Applied Psychology Health and Well-Being · doi:10.1111/aphw.70103 · Cited by 2 · see citing works

Discovery of 6,7-Dihydropyrazolo[1,5-a]pyrazin-4(5H)-one Derivatives as mGluR2 Negative Allosteric Modulators with In Vivo Activity in a Rodent’s Model of Cognition

de Diego, S. A. A., Linares, M. L., Molina, A. G., de Lucas, A. I., del Cerro, A., Alonso, J. M., Donck, L. V., Cid, J. M., Trabanco, A. A., & Gool, M. V. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01227 · Cited by 2 · see citing works

Clinical relevance of cognitive dysfunction in major depressive disorder

Cha, D. S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.002 · Cited by 2 · see citing works

The impact of depressive symptoms on cognitive impairments in chronic ketamine users

Zhang, C., Zhang, B., Xu, Y., Hao, W., & Tang, W. K. (2023) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2023.152448 · Cited by 2 · see citing works

Learning to deal with life's ups and downs

Heshmati, M., & Russo, S. J. (2013) · Nature Neuroscience · doi:10.1038/nn.3400 · Cited by 2 · see citing works

Beneficios potenciales de vortioxetina en el tratamiento del dolor crónico

Montero, A. A., & de Vasconcelos, S. R. P. (2021) · Neurology Perspectives · doi:10.1016/j.neurop.2021.03.001 · Cited by 1 · see citing works

Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.2 · Cited by 1 · see citing works

mGlu2/3 Receptor Antagonists as Rapid-Acting Antidepressants

Chaki, S. (2021) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-79790-4_7 · Cited by 1 · see citing works

Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic

Willard, I. S., & Koochekpour, S. (2013)

Emerging Role of Glutamate Receptors in Pathophysiology of Depression

Na, K., & Kim, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-6580-4_7

Further exploration of an N-aryl phenoxyethoxy pyridinone-based series of mGlu3 NAMs: Challenging SAR, enantiospecific activity and in vivo efficacy

Yamada, Y., Yohn, S. E., Gilliland, K. M., Loch, M. T., Schulte, M. I., Rodriguez, A. L., Blobaum, A. L., Niswender, C. M., Conn, P. J., & Lindsley, C. W. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.030

The Role of Functional Social Isolation in Mediating the Association Between Baseline Depression and Subsequent Executive Function in the Canadian Longitudinal Study on Aging Comprehensive Cohort

Iacono, A. J. (2021) · UWSpace (University of Waterloo)

Cognitive impairment and therapeutic response in resistant depression

Darmon, N., Bulsei, J., Gomez, S., Bruckert, H., Gugenheim, L., Riviere, K., Dandreis, M., Fontas, É., Giordana, J., & Benoît, M. (2024) · L Encéphale · doi:10.1016/j.encep.2024.02.002

Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024

Saleh, A. Y., Saputra, D. A. Y., Valentina, R., & Susanto, T. D. (2025) · F1000Research · doi:10.12688/f1000research.160416.1 · Cited by 1 · see citing works

Long-term outcome of perinatal stress : targeting the oxytocinergic system in the early prevention of stress-related disorders

Gatta, E. (2016) · theses.fr (ABES) · doi:10.70675/eb10021dz791ez4d44z8f03zb272dfadb7fb

Le récepteur métabotropique du glutamate mGlu2 interagit avec et transactive le récepteur tyrosine kinase TrkB : rôle dans la réponse comportementale aux antipsychotiques glutamatergiques

Philibert, C. E. (2022) · theses.fr (ABES) · doi:10.70675/69624d58z05e6z4829zb007z34385cc86305

The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression

Kvarta, M. D., Watanabe, M., Ozaki, S., Greenstein, D. K., Fijtman, A., Jones, G. H., Hu, H., Azimipour, S., Yuan, P., Johnston, J. N., et al. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002246

BindingDB Entry 50001388: Design and Synthesis of

BindingDB (2020) · UC San Diego · doi:10.7270/q2zp48nj

BindingDB Entry 50007796: Further exploration of an N-aryl phenoxyethoxy pyridinone-based series of mGlu

BindingDB (2021) · UC San Diego · doi:10.7270/q2kp85hm

BindingDB Entry 50046631: Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.

BindingDB (2016) · UC San Diego · doi:10.7270/q2h9970p

Cognitive impairment in major depressive disorder

Suciu, B. D., Panescu, R., & Micluția, I. (2017) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2017.1.3 · Cited by 4 · see citing works

9. A Cognitive Biotype of Depression Linking Symptoms, Behavior Measures, Neural Circuits, and Treatment Outcomes

Hack, L. M., Tozzi, L., Zenteno, S., Olmsted, A. M., Hilton, R. A., Yesavage, J. A., Schatzberg, A. F., O'Hara, R. M., & Williams, L. M. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.02.192 · Cited by 3 · see citing works

Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review

Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181 · see citing works

Advances in the Treatment of Cognitive Impairment in Major Depressive Disorder: Innovations and Research Challenges

Thakur, A., Jain, P., Sharma, M. K., Chauhan, N. S., Khatoon, N., Sahu, D., Ajazuddin, & Tamrakar, S. (2026) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-026-00331-7

Cognitive Enhancement in Major Depressive Disorder

Carvalho, A. F., Alves, G. S., Köhler, C. A., & McIntyre, R. S. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190214401.003.0010